Leading the Vascular and Endovascular Surgery Society (VESS) has been a great honor. Our society represents many things to many people, for me its friendship, support, knowledge, and growth. While Presidential addresses are a new thing for me, but don’t be surprised, I may veer back to aortic surgery once or twice. Maybe just maybe, I will have other opportunities to address my colleagues en-masse, but since this may be my last shot at this, I really thought hard what I could say. I worried about being to tangential, or not having enough quips to keep people interested, or just not having anything worth saying.
Complex aneurysmal lesions of the renal artery are best treated by ex-vivo surgery which allows arterial replacement by an autologous graft with nephronic protection, followed by an autograft. We report the long-term results of a continuous bicentric series using a pararectal retroperitoneal approach.
To evaluate the short and midterm consequences on the renal function and the mortality of the coverage of polar renal arteries during the endovascular treatment of juxtarenal aneurysms (JRA) with fenestrated stentgrafts.
The objective was to estimate the evolution of the surgical management as well as the postoperative morbi-mortality of abdominal aortic aneurysms (AAA) in France.
Bioprotec venous allografts are widely used but their precise evaluation is lacking.
Venous thrombosis of a kidney graft (GVT) is rare and of poor prognosis with a frequent loss of the graft. The primary aim was to identify the risk factors of early GVT (EGVT) in the first seven postoperative days. The secondary objective was to evaluate the incidence of EGVT.
Aortic infection is a serious disease, representing a therapeutic challenge. In situ reconstruction is currently privileged compared to extra-anatomical reconstruction. The problems lie in the choice of the best substitute. The objective of this study was to evaluate the results of the biological vascular patches to treat native or prosthetic infections of the abdominal aorta.
Endarterectomy with or without patch angioplasty is regarded as the treatment of reference of the stenoses of the common femoral artery (CFA). However, the use of active stents in the treatment of acute coronary syndromes (ACS) increases and requires the continuation of a double antiplatelet aggregation (APA) during a minimum of three months. Endovascular techniques as an alternative to conventional surgery might be less invasive to treat these severe lesions of the CFA. We analyzed the results of atherectomy in these patients at high hemorrhagic risk compared to endarterectomy to treat CFA lesions in patients admitted for a critical lower limb ischemia.
The brachial artery is an interesting alternative for the peripheral endovascular treatments in the event of hostile groins, lesions of the femoral tripod, complex procedures requiring several vascular accesses, but also because it allows an upper route of navigation. Since the literature reports high rates of complications for this access, we conducted a 6-month multicentric prospective study to reappraise its risks.
The SCVE recently published guidelines for the management in ambulatory hospitalization (AH) of the patients treated for peripheral occlusive arterial disease (POAD) by endovascular techniques. However the fear of an early re-hospitalization remains an obstacle to the development of AH. We compared the rates of re-hospitalization and complications of AH and of the conventional hospitalization (CH) in patients treated for POAD by endovascular techniques in France.